10 Biggest Price Target Changes For Wednesday
SVB Leerink cut the price target on TCR2 Therapeutics Inc. (NASDAQ: TCRR) from $7 to $3. TCR2 Therapeutics shares rose 16% to close at $3.19 on Tuesday.
Truist Securities Maintains Buy on AAR, Raises Price Target to $58
Truist Securities analyst Michael Ciarmoli maintains AAR (NYSE:AIR) with a Buy and raises the price target from $53 to $58.
5 Stocks To Watch For March 23, 2022
Some of the stocks that may grab investor focus today are:
AAR: Q3 Earnings Insights
AAR (NYSE:AIR) reported its Q3 earnings results on Tuesday, March 22, 2022 at 04:10 PM.
Here's what investors need to know about the announcement.
Earnings
AAR beat estimated earnings by 8.62%, reporting an EPS of $0.63 versus an estimate of $0.58.
Earnings Outlook For AAR
AAR (NYSE:AIR) is set to give its latest quarterly earnings report on Tuesday, 2022-03-22. Here's what investors need to know before the announcement.
Analysts estimate that AAR will report an earnings per share (EPS) of $0.58.
AAR Inks Exclusive Distribution Agreement With Collins Aerospace
AAR Corp. (NYSE:AIR) has inked an exclusive distribution agreement with Collins Aerospace’s Goodrich De-Icing & Specialty Heating Systems business. Deal terms…
AAR Signs Exclusive Distribution Agreement With Collins Aerospace’s Goodrich De-Icing & Specialty Heating Systems Business
AAR (NYSE:AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, has signed an exclusive distribution agreement with Collins Aerospace's Goodrich De-Icing &
20 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
BioRestorative Therapies, Inc. (NASDAQ: BRTX) rose 48.1% to $6.77 in pre-market trading after the company entered into a Master Service Agreement with PRC Clinical, a contract research organization (CRO), to conduct BioRestorative's Phase 2 trial.
